EU Stands Firm on AI Act Timeline Despite Industry Pushback

Reviewed byNidhi Govil

14 Sources

The European Union reaffirms its commitment to implementing the AI Act as scheduled, rejecting calls from tech companies for a delay. This decision highlights the ongoing tension between regulation and innovation in the rapidly evolving AI sector.

EU Reaffirms AI Act Implementation Timeline

The European Union has firmly stated that it will adhere to the original timeline for implementing its landmark AI legislation, despite mounting pressure from tech companies to delay the rollout. European Commission spokesperson Thomas Regnier emphasized, "There is no stop the clock. There is no grace period. There is no pause," in response to industry calls for postponement 1.

Industry Push for Delay

A coalition of over 110 organizations, representing a market capitalization of more than $3 trillion and 3.7 million jobs across Europe, has been urging the European Commission to delay the enforcement of the AI Act 2. Tech giants such as Alphabet, Meta, Mistral AI, and ASML are among those advocating for a two-year postponement, citing concerns about European competitiveness in the rapidly evolving AI landscape 3.

Source: euronews

Source: euronews

Key Provisions and Timeline

The AI Act, a risk-based regulation for artificial intelligence applications, includes several key provisions:

  1. Bans on "unacceptable risk" use cases like cognitive behavioral manipulation and social scoring.
  2. Regulations for "high-risk" uses such as biometrics, facial recognition, and AI in education and employment.
  3. Lighter transparency obligations for "limited risk" applications like chatbots 1.

The implementation of the Act is staggered, with some provisions already in effect since August 1, 2024. Crucial deadlines include:

  • August 2, 2025: Rules for general purpose AI (GPAI) models come into force.
  • August 2026: Full implementation of the Act 3.

Industry Concerns and EU Response

Tech companies argue that the rapid enforcement of the AI Act could stifle innovation and put European firms at a disadvantage. They cite concerns about compliance costs, lack of clear guidelines, and the potential impact on smaller companies with limited resources 4.

However, the EU remains committed to its timeline. The European Commission plans to propose steps to simplify its digital rules towards the end of the year, potentially easing reporting obligations for small companies 4.

Global Context and Criticism

Source: PYMNTS

Source: PYMNTS

The push for delay in EU AI regulation mirrors similar efforts in the United States, where some companies have sought a ten-year moratorium on state AI regulation 2. Critics, such as Corporate Observatory Europe, view these delay tactics as part of a "lobby playbook" to weaken rules protecting against biased and unfair AI systems 2.

Looking Ahead

Source: TechCrunch

Source: TechCrunch

As the August 2025 deadline for GPAI model regulations approaches, the EU faces the challenge of balancing its regulatory goals with the concerns of the tech industry. The Commission's commitment to publishing the AI Code of Practice before the August deadline may provide some clarity for companies preparing to comply with the new rules 3. The ongoing debate highlights the complex interplay between regulation, innovation, and global competitiveness in the rapidly evolving field of artificial intelligence.

Explore today's top stories

Capgemini Acquires WNS for $3.3 Billion to Boost AI-Powered Intelligent Operations

French tech giant Capgemini agrees to acquire US-listed WNS Holdings for $3.3 billion, aiming to strengthen its position in AI-powered intelligent operations and expand its presence in the US market.

euronews logoSilicon Republic logoAnalytics India Magazine logo

10 Sources

Business and Economy

7 hrs ago

Capgemini Acquires WNS for $3.3 Billion to Boost AI-Powered

Google DeepMind's Isomorphic Labs Nears Human Trials for AI-Designed Drugs

Isomorphic Labs, a subsidiary of Alphabet, is preparing to begin human trials for drugs developed using artificial intelligence, potentially revolutionizing the pharmaceutical industry.

Fortune logoBenzinga logoDigit logo

3 Sources

Science and Research

15 hrs ago

Google DeepMind's Isomorphic Labs Nears Human Trials for

BRICS Nations to Advocate for AI Data Protection and Fair Compensation

BRICS leaders are set to call for protections against unauthorized AI use, addressing concerns over data collection and fair payment mechanisms during their summit in Rio de Janeiro.

Reuters logoU.S. News & World Report logoMarket Screener logo

3 Sources

Policy and Regulation

23 hrs ago

BRICS Nations to Advocate for AI Data Protection and Fair

Huawei's AI Lab Refutes Accusations of Copying Alibaba's Model in Pangu Pro Development

Huawei's AI research division, Noah Ark Lab, denies allegations that its Pangu Pro large language model copied elements from Alibaba's Qwen model, asserting independent development and adherence to open-source practices.

Bloomberg Business logoReuters logoEconomic Times logo

3 Sources

Technology

7 hrs ago

Huawei's AI Lab Refutes Accusations of Copying Alibaba's

Samsung's Q2 Profit Expected to Plunge 39% Amid AI Chip Supply Challenges

Samsung Electronics is forecasted to report a significant drop in Q2 operating profit due to delays in supplying advanced memory chips to AI leader Nvidia, highlighting the company's struggles in the competitive AI chip market.

Reuters logoMarket Screener logo

2 Sources

Business and Economy

15 hrs ago

Samsung's Q2 Profit Expected to Plunge 39% Amid AI Chip
TheOutpost.ai

Your Daily Dose of Curated AI News

Don’t drown in AI news. We cut through the noise - filtering, ranking and summarizing the most important AI news, breakthroughs and research daily. Spend less time searching for the latest in AI and get straight to action.

© 2025 Triveous Technologies Private Limited
Instagram logo
LinkedIn logo